Is PPCBD or XYLD a better dividend investment in 2026?

PPCBD currently yields 35.21% with a 5% 5-year dividend growth rate. XYLD yields 10.98% with 0.5% growth. The better choice depends on your goal: PPCBD offers higher current income.

What is the dividend yield difference between PPCBD and XYLD?

PPCBD has a forward dividend yield of 35.21% ($2.00/share annually). XYLD yields 10.98% ($4.30/share annually). The yield gap is 24.23 percentage points.

Home › Compare › PPCBD vs XYLD

PPCBD vs XYLD: Dividend Comparison 2026

PPCBD yields 35.21% · XYLD yields 10.98%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 PPCBD wins by $152.7K in total portfolio value

INVESTMENT

TIME HORIZON10 years

PPCBD

● Live price

35.21%

Share price

$5.68

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$178.0K

Annual income

$27,022.57

Full PPCBD calculator →

XYLD

Global X S&P 500 Covered Call ETF

● Live price

10.98%

Share price

$39.13

Annual div

$4.30

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.3K

Annual income

$3,219.02

Full XYLD calculator →

Portfolio growth — PPCBD vs XYLD

📍 PPCBD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	PPCBD	XYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, PPCBD + XYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

PPCBD pays

XYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PPCBD

Annual income on $10K today (after 15% tax)

$2,992.96/yr

After 10yr DRIP, annual income (after tax)

$22,969.18/yr

XYLD

Annual income on $10K today (after 15% tax)

$933.63/yr

After 10yr DRIP, annual income (after tax)

$2,736.17/yr

At 15% tax rate, PPCBD beats the other by $20,233.02/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PPCBD + XYLD for your $10,000?

PPCBD: 50%XYLD: 50%

100% XYLD50/50100% PPCBD

Portfolio after 10yr

$101.6K

Annual income

$15,120.79/yr

Blended yield

14.88%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PPCBD buys

XYLD buys

No recent congressional trades found for PPCBD or XYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricPPCBDXYLD

Forward yield	35.21% ✓	10.98%
Annual dividend / share	$2.00	$4.30 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$178.0K ✓	$25.3K
Annual income after 10y	$27,022.57 ✓	$3,219.02
Total dividends collected	$128.7K ✓	$19.6K
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: PPCBD vs XYLD ($10,000, DRIP)

Year	PPCBD Portfolio	PPCBD Income/yr	XYLD Portfolio	XYLD Income/yr	Gap
1← crossover	$14,221	$3,521.13	$10,818	$1,098.39	+$3.4K → PPCBD
2	$19,896	$4,679.85	$11,738	$1,222.51	+$8.2K → PPCBD
3	$27,408	$6,119.13	$12,774	$1,364.64	+$14.6K → PPCBD
4	$37,205	$7,877.95	$13,944	$1,527.86	+$23.3K → PPCBD
5	$49,803	$9,994.16	$15,270	$1,715.87	+$34.5K → PPCBD
6	$65,793	$12,503.21	$16,775	$1,933.09	+$49.0K → PPCBD
7	$85,835	$15,436.81	$18,490	$2,184.87	+$67.3K → PPCBD
8	$110,665	$18,821.76	$20,450	$2,477.63	+$90.2K → PPCBD
9	$141,091	$22,678.96	$22,697	$2,819.19	+$118.4K → PPCBD
10	$177,990	$27,022.57	$25,280	$3,219.02	+$152.7K → PPCBD

PPCBD vs XYLD: Complete Analysis 2026

PPCBD — Stock

Propanc Biopharma, Inc., a biopharmaceutical company, develops cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia. Its lead product is PRP, a formulation that is in preclinical phase of development designed to enhance the anti-cancer effects of multiple enzymes. The company has a research collaboration with University of Jaén that undertakes the research activities for POP1 joint drug discovery program; and a joint research and drug discovery program with Universities of Jaén and Granada to investigate the changes in genetic and protein expression that occur in cancer cells. The company was formerly known as Propanc Health Group Corporation and changed its name to Propanc Biopharma, Inc. in April 2017. Propanc Biopharma, Inc. was incorporated in 2007 and is based in Camberwell, Australia.

Full PPCBD Calculator →

XYLD — ETF

The Global X S&P 500 Covered Call ETF (XYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe S&P 500 BuyWrite Index.

Full XYLD Calculator →

📬

Get this PPCBD vs XYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PPCBD vs SCHD PPCBD vs JEPI PPCBD vs O PPCBD vs KO PPCBD vs MAIN PPCBD vs QYLD PPCBD vs JEPQ PPCBD vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.